Patients receiving medication through South Africa’s public healthcare system may notice changes in the colour, shape, packaging or manufacturer of their medicines.
Image: Pixabay
Patients using medication through South Africa’s public healthcare system may sometimes find that their medicine looks different from what they received previously.
A tablet may have a different colour or shape, while its packaging or manufacturer may also change. According to the Department of Health, these changes do not necessarily mean patients have been given a different medicine.
The department says public healthcare facilities procure medicines only from suppliers that meet stringent regulatory and quality standards. Where more than one approved supplier provides the same medicine, patients may receive products from different manufacturers over time.
Although the medicines may look different, they contain the same active ingredients, are of the same strength and quality, and provide the same therapeutic benefits. They are approved as safe, effective and interchangeable.
For patients, this means an unfamiliar-looking medicine does not necessarily mean their treatment has changed. Healthcare professionals may dispense an equivalent medicine to ensure treatment continues without interruption.
Medicine shortages can also be more complicated than a particular medicine simply being unavailable.
The Department of Health says a specific brand, pack size or supplier's product may be temporarily unavailable while an equivalent medicine remains accessible. Healthcare professionals routinely manage these situations by providing clinically appropriate alternatives to maintain continuity of care.
South Africa's medicine supply chain can occasionally be affected by factors outside the health system's control, including manufacturing disruptions, global shortages of raw materials, increased international demand, transport delays and changes between procurement contracts.
The department says it monitors medicine availability through the National Surveillance Centre and established reporting systems, including the web-based Stock Visibility System. These systems provide early warning of potential supply challenges and allow the National Department of Health to work with provinces, healthcare facilities, suppliers and regulatory authorities to address risks.
Patients who are concerned about a change in the appearance of their medicine are encouraged to speak to their doctor, pharmacist or nurse. Healthcare professionals can explain why the medicine looks different and confirm that it remains appropriate for their treatment.
The Department of Health says it remains committed to ensuring patients receive safe, effective and quality-assured medicines through the public health system.
IOL
Related Topics:
